In the US, we pay more for prescription drugs than ANY OTHER COUNTRY. By a lot – more than double. The reason for this is complicated. And the amount of attention brought to this issue ebbs and flows. Last week, a bunch of pissed-off parents made it clear that the epic price hike on the EpiPen (used for major life-threatening allergy attacks) was not an acceptable move on the part of drug manufacturer Mylan — the same company whose CEO received a 671% salary increase in just eight years from under $3M to over $18M.
Luckily, I don’t have allergies or the need for an EpiPen – which now costs $400 per pen or about $415 after insurance for two pens. In Canada, a hop, skip, and snowshoe north of our borders, the pens are distributed by Pfizer and cost just $100 a pen. In France, the pens cost $85. Perhaps allergies in Canada are not as vicious as those in the States? Maybe French people are allergic to allergies so they just don’t get them? No — the EpiPen in all countries serves the same exact purpose… it’s just a lot more expensive to acquire in the US. Continue reading